AXA Framlington Biotech Fund - Z Acc
This fund can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment
Before investing please read:
Management
| Name of company | AXA Investment Managers UK Ltd |
| Phone | 44 20 7003 2345 |
| Website | www.axa-im.com |
| Address | 22 Bishopsgate - London EC2N 4BQ United Kingdom |
Fund
| Domicile | GBR |
| Legal structure | Unit Trust |
| UCITS | Yes |
| Inception date | 16/04/2012 |
Managers
| Fund manager | Chris Eccles |
| Manager start date | 29/03/2024 |
| Biography | Chris Eccles is a research analyst who specialises in testing and regulatory affairs. He researches stocks globally and focuses on the Healthcare sector.Chris joined Impax in March 2019. He started working in the financial industry in 2011 as a research analyst at Morgan Stanley where he focused on European large-cap pharmaceuticals. In 2014, he became a partner at the hedge fund Kola Capital where he worked as a global equities analyst for three years before moving to Stifel in 2017 to work as a Healthcare Specialist.Chris achieved an MA (Oxon) Physiological Sciences First Class Honours, from the University of Oxford. |
| Fund manager | Cinney Zhang |
| Manager start date | 29/03/2024 |
| Biography | - |
| Fund manager | Catherine Tennyson |
| Manager start date | 29/03/2024 |
| Biography | - |